- Home
- OLMA vs LFCR Comparison
OLMA vs LFCR Comparison
Compare OLMA & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLMA
- LFCR
- Stock Information
- Founded
- OLMA 2006
- LFCR 1986
- Country
- OLMA United States
- LFCR United States
- Employees
- OLMA N/A
- LFCR N/A
- Industry
- OLMA Biotechnology: Pharmaceutical Preparations
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- OLMA Health Care
- LFCR Health Care
- Exchange
- OLMA Nasdaq
- LFCR Nasdaq
- Market Cap
- OLMA 289.0M
- LFCR 242.5M
- IPO Year
- OLMA 2020
- LFCR N/A
- Fundamental
- Price
- OLMA $4.11
- LFCR $6.85
- Analyst Decision
- OLMA Strong Buy
- LFCR Buy
- Analyst Count
- OLMA 4
- LFCR 3
- Target Price
- OLMA $26.75
- LFCR $8.00
- AVG Volume (30 Days)
- OLMA 939.3K
- LFCR 175.2K
- Earning Date
- OLMA 03-18-2025
- LFCR 01-02-2025
- Dividend Yield
- OLMA N/A
- LFCR N/A
- EPS Growth
- OLMA N/A
- LFCR N/A
- EPS
- OLMA N/A
- LFCR N/A
- Revenue
- OLMA N/A
- LFCR $130,858,000.00
- Revenue This Year
- OLMA N/A
- LFCR $2.24
- Revenue Next Year
- OLMA N/A
- LFCR $7.88
- P/E Ratio
- OLMA N/A
- LFCR N/A
- Revenue Growth
- OLMA N/A
- LFCR 16.47
- 52 Week Low
- OLMA $3.93
- LFCR $3.68
- 52 Week High
- OLMA $16.62
- LFCR $7.99
- Technical
- Relative Strength Index (RSI)
- OLMA 37.74
- LFCR 67.57
- Support Level
- OLMA $3.93
- LFCR $6.20
- Resistance Level
- OLMA $4.45
- LFCR $6.95
- Average True Range (ATR)
- OLMA 0.31
- LFCR 0.29
- MACD
- OLMA 0.04
- LFCR 0.04
- Stochastic Oscillator
- OLMA 21.95
- LFCR 89.36
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.